This spring Chris Montalbano (Principal of MIDI) served as a Biomedical Judge & Adviser for Columbia-Coulter’s Translational Research Foundation, assisting various teams interested in commercializing their biotechnologies by applying relevant experience and expertise within this market. The process afforded participants a holistic perspective to think past their technology to the broader challenges involved with biomedical commercialization. By engaging and allowing the team’s access to early advisement its participants receive specific guidance and strategic direction on the challenges they may face during the development path to market.

Last week the event concluded with judging, where selected teams receive Coulter Funding to advance their nascent ideas from conception to proof-of-concept. The program aims to better position these ideas for partnering with a commercial entity that will invest the necessary resources to bring the concept to market.